DANIEL C. ALLEN

Corporate Board Profile

Tech Score: 0/100

PharmaCyte Biotech, Inc.

Filing Date	Source Excerpt
2022-11-25	Mr. Allen has served as the Managing Partner of Corona Park Investment Partners, a firm he founded, since 2013. Mr. Allen has also served as the Executive Chairman of Zagg, a global leader in mobile accessories and technologies. Mr. Allen previously served as Executive Chairman of Printronix, a global leader in industrial printers. He has also served as a director of publicly traded SharpSpring, Inc. prior to its acquisition. Prior to forming Corona Park Investment Partners, Mr. Allen worked for nearly a decade at Bain Capital, where he led more than a dozen investments in venture and late-stage technology companies. He also served as a strategy consultant at McKinsey and Company.

Filing Date

Source Excerpt

2022-11-25

Mr. Allen has served as the Managing Partner of Corona Park Investment Partners, a firm he founded, since 2013. Mr. Allen has also served as the Executive Chairman of Zagg, a global leader in mobile accessories and technologies. Mr. Allen previously served as Executive Chairman of Printronix, a global leader in industrial printers. He has also served as a director of publicly traded SharpSpring, Inc. prior to its acquisition. Prior to forming Corona Park Investment Partners, Mr. Allen worked for nearly a decade at Bain Capital, where he led more than a dozen investments in venture and late-stage technology companies. He also served as a strategy consultant at McKinsey and Company.

Data sourced from SEC filings. Last updated: 2026-02-03